NeuroSense Therapeutics Ltd. Quarterly Assets in USD from Q4 2022 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: NeuroSense Therapeutics Ltd. quarterly Assets history and growth rate from Q4 2022 to Q4 2024.
NeuroSense Therapeutics Ltd. Assets for the quarter ending December 31, 2024 was $4.58M, a 43.6% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$4.58M	+$1.39M	+43.6%	Dec 31, 2024	20-F	2025-04-07
Q2 2024	$1.84M	-$6.03M	-76.6%	Jun 30, 2024	6-K	2024-09-30
Q4 2023	$3.19M	-$4.53M	-58.7%	Dec 31, 2023	20-F	2025-04-07
Q4 2022	$7.72M	-$3.71M	-32.5%	Dec 31, 2022	6-K	2024-06-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.